Cargando…
Zidovudine.
Zidovudine was the first agent approved for treatment of HIV disease, and since its widespread availability in 1987, the pharmacokinetic disposition and clinical effects of ZDV have been extensively evaluated. In addition to its utility as a component of a multidrug combination regimen for the treat...
Autor principal: | Sperling, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784811/ https://www.ncbi.nlm.nih.gov/pubmed/9894173 http://dx.doi.org/10.1002/(SICI)1098-0997(1998)6:5<197::AID-IDOG2>3.0.CO;2-1 |
Ejemplares similares
-
Zidovudine-induced myopathy
por: Wiwanitkit, Viroj
Publicado: (2011) -
Zidovudine Induced Hyperpigmentation
por: Premjith, Raveendran, et al.
Publicado: (2022) -
Placental Transport of Zidovudine in the Rhesus Monkey
por: Ridgway III, Louis E., et al.
Publicado: (1993) -
Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus
por: Cong, Yu, et al.
Publicado: (2016) -
Effect of Zidovudine and its Interaction with Rocuronium on Neuromuscular Transmission
por: Barvaliya, M. J., et al.
Publicado: (2013)